The Assessment ofProteus mirabilisSusceptibility to Ceftazidime and Ciprofloxacin and the Impact of These Antibiotics at Subinhibitory Concentrations onProteus mirabilisBiofilms

Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections

(2012) R Wasfi et al.   Indian Journal of Medical Microbiology

Proteus mirabilis urinary tract infection and bacteremia: Risk factors, clinical presentation, and outcomes

(2012) Chi-Yu Chen et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

The clinical impact of bacterial biofilms

(2011) Niels Høiby et al.   International Journal of Oral Science

Proteus mirabilisbiofilms and catheter-associated urinary tract infections

(2011) Sandra M. Jacobsen et al.   Virulence

Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS), 2003–2008

(2010) Hui Wang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Rapidly spreading CTX-M-type β-lactamase-producing Proteus mirabilis in Japan

(2010) Akiko Kanayama et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antibiotic resistance of bacterial biofilms

(2010) Niels Høiby et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Changes in bacterial isolates from burn wounds and their antibiograms: A 20-year study (1986–2005)

(2009) Merlin Guggenheim et al.   BURNS

Epidemiology of Antimicrobial Resistance among Gram-Negative Organisms Recovered from Patients in a Multistate Network of Long-Term Care Facilities

(2009) Ebbing Lautenbach et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Signals, Regulatory Networks, and Materials That Build and Break Bacterial Biofilms

(2009) E. Karatan et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Prevalence and characterization of extended-spectrum β-lactamase–producing Enterobacteriaceae isolated in Korean hospitals

(2008) Kwan Soo Ko et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE